Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
HHS-NIH11 Posted PAR-25-296
Close Date:
October 19, 2027
598 days remaining
Description
The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.
Eligibility
Other Eligible Applicants include the following:
See NOFO for further eligibility criteria.
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
See NOFO for further eligibility criteria.
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- $650,000.00
- Total Estimated Funding
- $650,000.00
- Expected Awards
- Not specified
Key Dates
- Posted
- December 11, 2024
- Closes
- October 19, 2027 598d
- Archive Date
- November 24, 2027
Agency Information
- Agency Name
- HHS-NIH11
- Agency Code
- HHS-NIH11
- Funding Instrument
- Other